Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients

Silvia Mangiacavalli, GianMatteo Pica, Marzia Varettoni, Mario Lazzarino, Alessandro Corso

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)240-241
Number of pages2
JournalEuropean Journal of Haematology
Volume82
Issue number3
DOIs
Publication statusPublished - Mar 2009

ASJC Scopus subject areas

  • Hematology

Cite this

Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients. / Mangiacavalli, Silvia; Pica, GianMatteo; Varettoni, Marzia; Lazzarino, Mario; Corso, Alessandro.

In: European Journal of Haematology, Vol. 82, No. 3, 03.2009, p. 240-241.

Research output: Contribution to journalArticle

@article{36054180d028461a865e445da3c90a43,
title = "Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients",
author = "Silvia Mangiacavalli and GianMatteo Pica and Marzia Varettoni and Mario Lazzarino and Alessandro Corso",
year = "2009",
month = "3",
doi = "10.1111/j.1600-0609.2008.01184.x",
language = "English",
volume = "82",
pages = "240--241",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",

}

TY - JOUR

T1 - Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients

AU - Mangiacavalli, Silvia

AU - Pica, GianMatteo

AU - Varettoni, Marzia

AU - Lazzarino, Mario

AU - Corso, Alessandro

PY - 2009/3

Y1 - 2009/3

UR - http://www.scopus.com/inward/record.url?scp=58849114126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849114126&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2008.01184.x

DO - 10.1111/j.1600-0609.2008.01184.x

M3 - Article

C2 - 19018860

AN - SCOPUS:58849114126

VL - 82

SP - 240

EP - 241

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 3

ER -